• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Donor Deferral of MSM May Inappropriately Conflate Group Membership with Individual Risk

December 21, 2012

A review from researchers at Case Western Reserve University suggests that the Food and Drug Administration (FDA) policy of deferring donors who are or have been men who have sex with men (MSM) inappropriately conflates group membership with individual HIV risk. Published in the journal Transfusion Medicine Reviews, the researchers assessed donor education materials collected from 52 community blood centers and hospital blood banks to evaluate definitions of HIV/AIDS risk behaviors and associated terms. They found that the majority of materials were based on the AABB’s “Making Your Blood Donation Safe” document, and did not clearly define “risky sexual behavior.” Furthermore, the analysis demonstrated that the term “sexual contact” was broadly defined and not clearly linked to specific risk behaviors. By excluding all MSM (even men who had sex with another man only one time) from donation, individuals who may be at very low risk of HIV are implicitly constructed as HIV positive. The authors conclude the MSM exclusion may be an inappropriate deferral policy. FDA guidelines have been highly contested in the past decade, but remain unchanged.

Reference

1.     Cascio MA, Yomtovian R. Sex, risk, and education in donor educational materials: review and critique. Transfus Med Rev 2013;27: 50-5.

Filed Under

  • Blood Donation
  • News

Recommended

  • NIH Urges Randomized Controlled Trials for COVID-19 Convalescent Plasma

  • Restrictive Platelet Transfusions Superior in Preterm Infants with Thrombocytopenia

  • Platelets Stored for 6 to 7 Days Are Not Inferior to Platelets Stored for 2 to 5 Days for Stable Hematology Patients

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley